위염치료제의 임상시험평가지침 연구 = Guideline for the Clinical Trials Evaluation for Gastritis

다국어 초록 (Multilingual Abstract)

Gastritis is the most common disease among Korean. The demand for the development of gastritis drugs has been increasing. Currently, however, there is no guideline available for the clinical evaluation of gastritis drugs worldwide. As a consequence, domestic and international pharmaceutical companies make errors in the drug development processes, and it becomes difficult for them to establish the scientific validity and objectivity of newly developed drugs. The objective of this study was to develop the Guideline for Clinical Trials Evaluation of Gastritis which can be used in improving the quality and consistency of clinical trials. First, we collected and reviewed the clinical trials on gastritis drugs that were available from Japan Pharmaceuticals and Medical Devices Agency and Korea Food and Drug Administration (KFDA), and investigated the recent research trends on clinical trials of gastritis drugs. Reviewers from KFDA and National Institute of Food and Drug Safety Evaluation and scientific experts from the pharmaceutical industries developed the guidelines through regularly scheduled meetings. Opinions and consultation from academic fields and industry experts were also obtained. This project will provide the clinical trial practitioners, investigator and reviewers the scientific and rational guidelines for performance and evaluation of clinical trials for gastritis drugs. Furthermore, we hope this guideline contributes to establishing the national competitiveness, improving the quality of clinical trial, and encouraging researches on drug development for gastritis.

참고문헌 (Reference)

1 최명규, "위염에 대한 레바프라잔 정제의 제3상 임상시험" 대한소화기내시경학회 33 (33): 212-219, 2006

2 정정조, "위염 환자에서 글립타이드？정(Sulglycotide 200 mg)의 치료 효과를 평가하기 위한 단일맹검, 무작위 배정, 비교약 대조, 다기관 임상시험" 대한소화기내시경학회 35 (35): 125-132, 2007

3 설상영, "미란성 위염에 대한 Stillen 캅셀의 3상 임상시험" 대한소화기내시경학회 28 (28): 230-236, 2004

4 이용찬, "Pathophysiology로 이해하는 내과학 - 6. 소화기질환" 정담, 서울 71-, 2008

5 지삼룡, "Gastritis" 29 : 22-, 2004

6 Schenk, B. E, "Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy" 46 : 615-, 2000

7 Seol, S. Y, "DA-9601 for erosive gastritis: results of a doubleblind placebo-controlled phase III clinical trial" 10 : 2379-, 2004

8 高久史, "2009 Drugs in Japan (Ethical Drugs)" Jiho, lnc 1710-2772, 2009